58-Week Open-label trial of Tavapadon in Parkinson's Disease (Tempo-4 Trial) (H-48638)
Description
Content
Cerevel has begun a study of an investigational drug called CVL-751 (also known as Tavapadon) as a possible treatment for Parkinson's disease. An investigational drug is one that has not been approved by the United States (US) Food and Drug Administration (FDA).
The main purpose of this study is to learn how well the study drug works and how safe the study drug is.
Contact
Phone 1: 713–798–5989
IRB: H-48638
Status:
Active
Created:
